AbbVie posted higher fourth-quarter revenue on the back of growth from its immunology portfolio, led by arthritis and Crohn’s disease drugs Skyrizi and Rinvoq.
Source link
AbbVie Revenue Rises on Immunology Growth
Date:
More like thisRelated
These Tiny Startups Are Getting Even Smaller With Help From AI
By holding off on hiring, and sometimes eliminating existing...
Brazilian serial killer lived in the woods and was nicknamed “mosquito”
SAO PAULO -- A man who Brazilian authorities say...
Albuquerque woman held behind bars after she's accused of kidnapping grandson
ALBUQUERQUE, N.M. (KRQE) – A grandmother accused of kidnapping...